Feb 2019: IND application is now approved by the FDA for our lead compound BC-1261 (link)!
Feb 2019: Bill along with his colleagues Dr. Toren Finkel, Dr. Yuan Liu co-founded Genarian Pharmaceutical targeting Aging related diseases.
Jan 2019: IND application was submitted to the FDA for our lead compound BC-1261.
Jan 2019: Our longtime collaborator Dr. Yuan Liu and Dr. Michael Jurczak got an R01 application funded from NIDDK! Congratulations
Sept 2018: After years of struggle, we finally setup our first HTS system! Check out the HTS section.
Aug 2018: We moved our lab again! This time to the beautiful bridgeside point I by the river! Check out the photo section.
July 2018: Bill’s lead compound BC1261 (KT-1002) has reached clinical candidate status for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn’s Disease, after successfully completing IND-enabling studies. (link)
June 2018: We officially joined the newly founded University of Pittsburgh Aging Institute! (link)
June 2018: Johnny’s K08 (NHLBI) got funded! Congratulations to Dr. Evankovich!
May 2018: Travis’s F31 and AHA application got funded at the same time! 1% on the F31, WOW. Congratulations!
May 2018: Yanwen Chen Joined our lab. Welcome!
Feb 2018: Our longtime collaborator Dr. Yuan Liu got an R01 application funded from NHLBI! Congratulations!
Dec 2016: Bill’s lead compound BC1261 (Anti-inflammatory) has entered IND-enabling phase.
Sept 2016: Yao Tong Joined our lab. Welcome!
July 2016: Alison got into the PA school. Good luck Alison and we will miss you!
July 2016: Sarah got into the Law school. Good luck Sarah and we will miss you!
Oct 2015: Bill got a R01 grant funded from NHLBI! Congratulations!
May 2015: Travis gives oral presentation at ATS.